Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Specific T-cells for COVID-19
NCT04406064Phase 2Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2021
- Primary completion
- Jun 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of viral-specific T-cells in coronavirus disease 2019 (COVID-19), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Jan 2021; status: withdrawn.
02
Drugs
viral-specific T-cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04406064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406064.